Pattern of early visual field loss in HIV-infected patients

Archives of Ophthalmology

Volumn 117, Issue 6, 1999, Pages 755-760

  Sample, Pamela A ^a   Plummer, Daniel J ^a   Mueller, Arthur J ^a   Matsubara, Kim I ^a   Sadun, Alfredo ^c   Grant, Igor ^b   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA GANGLION CELL; RETINA INJURY; RETINA NEUROEPITHELIAL LAYER; SURVIVAL TIME; VISUAL FIELD DEFECT;

EID: 0033037743     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.6.755     Document Type: Article

References (31)

1. Geier SA, Held M, Bogner JR, et al. Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS. Br J Ophthalmol. 1993;77:315-316.
2. Geier SA, Kronawitter U, Bogner JR, et al. Impairment of colour contrast sensitivity and neuroretinal dysfunction in patients with symptomatic HIV infection or AIDS. Br J Ophthalmol. 1993;77:716-720.
3. Latkany PA, Holopigian K, Lorenzo-Latakany M, Seiple W. Electroretinographic and psychophysical findings during early and late stages of human immunodeficiency virus infection and cytomegalovirus retinitis. Ophthalmology. 1997;104:445-453.
4. Bachman DM, Bruni LM, DiGioia RA, et al. Visual field testing in the management of cytomegalovirus retinitis. Ophthalmology. 1992;99:1393-1399.
5. Geier SA, Hammel G, Bogner JR, et al. HIV-related ocular microangiopathic syndrome and color contrast sensitivity. Invest Ophthalmol Vis Sci. 1994;35:3011-3021.
6. Geier SA, Nohmeier C, Lachenmayr BJ, Klauss V, Goebel FD. Deficits in perimetric performance in patients with symptomatic human immunodeficiency virus infection or acquired immunodeficiency syndrome. Am J Ophthalmol. 1995; 119:335-344.
7. Iragui VJ, Kalmijn J, Plummer DJ, et al. Pattern electroretinograms and visual evoked potentials in HIV infection: evidence for asymptomatic retinal and postretinal impairment in the absence of infectious retinopathy. Neurology. 1996;47: 1452-1456.
8. Kozak LC, Bullimore MA. Visual changes in human immunodeficiency virus infection. Optom Vis Sci. 1994;71:557-561.
9. Mueller AJ, Berninger TA, Matuschke A, Klauss V, Goebel F-D. Elektroophthalmologische untersuchungen bei HIV-patienten. Fortschr Ophthalmol. 1991;88: 712-715.
10. Mueller AJ, Berninger TA, Geier S, Lachenmayr B, Klauss V. Electroophthalmologische und psychophysische Untersuchungen bei fundosckopisch unauffalligen HIV-positiven und AIDS-Patienten. Folia Ophthalmol. 1992;17:5-9.
11. Mueller AJ, Plummer DJ, Dua R, et al. Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol. 1997;124:158-167.
12. Mutlukan E, Dhillin B, Aspinall P, Cullen JF. Low contrast visual acuity changes in human immunodeficiency virus (HIV) infection. Eye. 1992;6:39-42.
13. Plummer DJ, Sample PA, Arevalo JF, et al. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol. 1996;122:542-549.
14. Plummer DJ, Marcotte TD, Sample PA, et al. Non-retinal visual field deficits are associated with neuropsychological impairment in HIV infection. Invest Ophthalmol Vis Sci. In press.
15. Quiceno JI, Capparelli E, Sadun AA, et al. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992; 113:8-13.
16. Visual field loss in glaucoma. In: Anderson DR, ed. Perimetry: With and Without Automation. St Louis, Mo: Mosby Inc; 1987:142-150.
17. Henricsson M, Heijl A. Visual fields at different stages of diabetic retinopathy. Acta Ophthalmol. 1994;72:560-569.
18. Flanagan DW. Current management of established diabetic eye disease. Eye. 1993; 7:302-308.
19. The American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-type 1) infection. Neurology. 1991;41:778-785.
20. Grant I, Heaton R, Marcotte T. Evaluating the neurocognitive complications of SLE: lessons from HIV disease. Ann N Y Acad Sci. 1997;823:18-43.
21. Gordon MO, Kass MA, eds. Ocular Hypertension Treatment Study (OHTS) Manual of Procedures. Vol 2.0. Bethesda, Md: National Institutes of Health; 1995.
22. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997;3:533-540.
23. + T-cell homeostasis and function in advanced HIV disease. Science. 1997; 277:112-116.
24. STATPAC User's Guide. San Leandro, Calif: Allergan-Humphrey; 1987.
25. Asman P, Heijl A. Glaucoma hemifield test for automated visual field evaluation. Arch Ophthalmol. 1992;110:812-819.
26. Weber J, Dannheim F, Dannheim D. The topographical relationship between optic disc and visual field in glaucoma. Acta Ophthalmol. 1990;68:568-574.
27. Weber J, Ulrich H. A perimetric nerve fiber bundle map. Int Ophthalmol. 1991; 15:193-200.
28. Yamagishi N, Anton A, Sample PA, et al. Mapping structural damage of the optic disk to visual field defect in glaucoma. Am J Ophthalmol. 1997;123:667-676.
29. Anton A, Yamagishi N, Zangwill L, Sample PA, Weinreb RN. Mapping structural to functional damage in glaucoma with standard automated perimetry and confocal scanning laser ophthalmoscopy. Am J Ophthalmol. 1998;125:436-446.
30. Choplin NT, Edwards RP, eds. Visual Field Testing With the Humphrey Visual Field Analyzer. Thorofare, NJ: Slack Inc; 1995.
31. Trick GL. Visual field loss in senile dementia of the Alzheimer's type. Neurology. 1995;45:68-74.